Assets, Current in USD of Neumora Therapeutics, Inc. from Q4 2022 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Neumora Therapeutics, Inc. quarterly Assets, Current history and growth rate from Q4 2022 to Q3 2025.
Neumora Therapeutics, Inc. Assets, Current for the quarter ending September 30, 2025 was $177M, a 49.2% decline year-over-year.

Assets, Current, Quarterly (USD)

Assets, Current, YoY Quarterly Growth (%)

Neumora Therapeutics, Inc. Quarterly Assets, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$177M	-$172M	-49.2%	Sep 30, 2025	10-Q	2025-11-06
Q2 2025	$223M	-$175M	-44%	Jun 30, 2025	10-Q	2025-08-06
Q1 2025	$255M	-$188M	-42.4%	Mar 31, 2025	10-Q	2025-05-12
Q4 2024	$314M	-$164M	-34.3%	Dec 31, 2024	10-Q	2025-11-06
Q3 2024	$349M	-$177M	-33.7%	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$398M			Jun 30, 2024	10-Q	2024-08-06
Q1 2024	$443M			Mar 31, 2024	10-Q	2024-05-07
Q4 2023	$478M	+$90.3M	+23.3%	Dec 31, 2023	10-K	2025-03-03
Q3 2023	$526M			Sep 30, 2023	10-Q	2023-11-01
Q4 2022	$388M			Dec 31, 2022	10-K	2024-03-07

* An asterisk sign (*) next to the value indicates that the value is likely invalid.